Related Experiment Videos
Microarrays in cancer research
Geraldine M Grant1, Amanda Fortney, Francesco Gorreta
1Department of Molecular Biology and Microbiology, George Mason University, 10900 University Blvd, Manassas, VA 20110, USA. ggrant1@gmu.edu
Anticancer Research
|May 22, 2004
Summary
This study uses microarray technology to analyze gene expression in various cancers, integrating clinical data to identify new molecular markers for cancer diagnosis and prognosis. The research aims to uncover key genes and pathways involved in cancer development and treatment resistance.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Cancer's polygenic nature presents challenges for traditional research.
- Microarray technology offers a powerful tool for simultaneous evaluation of cellular processes.
- Identifying molecular markers is crucial for improving cancer diagnosis and prognosis.
Purpose of the Study:
- To elucidate genes and pathways involved in various cancers.
- To identify novel molecular markers for cancer diagnosis and prognosis.
- To integrate clinical and molecular data for comprehensive cancer research.
Main Methods:
- Utilizing multiple microarray platforms (Affimetrix, Oligo-Chips, cDNA arrays) to analyze gene expression profiles.
- Developing a secure relational database to integrate clinical and histopathological data with gene expression data.
- Implementing stringent protocols for tissue acquisition, processing, and RNA integrity to ensure sample quality.
Main Results:
- Over 300 patients enrolled across multiple cancer types, with a focus on breast cancer.
- Development of protocols for tissue acquisition and processing to maintain sample and RNA integrity.
- Establishment of a comprehensive clinical database linked to gene expression data for multi-level analysis.
Conclusions:
- Seamless integration of clinical and molecular data is essential for advancing cancer research.
- Microarray technology holds significant promise for discovering new molecular markers in oncology.
- This collaborative effort aims to provide critical insights into cancer biology and treatment strategies.